Top

BMC Psychiatry

Published in:

Open Access 01-12-2016 | Study protocol

Meditation or Medication? Mindfulness training versus medication in the treatment of childhood ADHD: a randomized controlled trial

Authors: Renée Meppelink, Esther I. de Bruin, Susan M. Bögels

Published in: BMC Psychiatry | Issue 1/2016

Abstract

Background

Attention-Deficit-Hyperactivity-Disorder (ADHD) is, with a prevalence of 5 %, a highly common childhood disorder, and has severe impact on the lives of youngsters and their families. Medication is often the treatment of choice, as it currently is most effective. However, medication has only short-term effects, treatment adherence is often low and most importantly; medication has serious side effects. Therefore, there is a need for other interventions for youngsters with ADHD. Mindfulness training is emerging as a potentially effective training for children and adolescents with ADHD. The aim of this study is to compare the (cost) effectiveness of mindfulness training to the (cost) effectiveness of methylphenidate in children with ADHD on measures of attention and hyperactivity/impulsivity.

Methods/design

A multicenter randomized controlled trial with 2 follow-up measurements will be used to measure the effects of mindfulness training versus the effects of methylphenidate. Participants will be youngsters (aged 9 to 18) of both sexes diagnosed with ADHD, referred to urban and rural mental healthcare centers. We aim to include 120 families. The mindfulness training, using the MYmind protocol, will be conducted in small groups, and consists of 8 weekly 1.5-h sessions. Youngsters learn to focus and enhance their attention, awareness, and self-control by doing mindfulness exercises. Parents will follow a parallel mindful parenting training in which they learn to be fully present in the here and now with their child in a non-judgmental way, to take care of themselves, and to respond rather than react to difficult behavior of their child. Short-acting methylphenidate will be administered individually and monitored by a child psychiatrist. Assessments will take place at pre-test, post-test, and at follow-up 1 and 2 (respectively 4 and 10 months after the start of treatment). Informants are parents, children, teachers, and researchers.

Discussion

This study will inform mental health care professionals and health insurance companies about the clinical and cost effectiveness of mindfulness training for children and adolescents with ADHD and their parents compared to the effectiveness of methylphenidate. Limitations and several types of bias that are anticipated for this study are discussed.

Trial registration

Dutch Trial Register: NTR4206. Registered 11 October 2013.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Arlington: American Psychiatric Pub; 2013.

Le HH, Hodgkins P, Postma MJ, Kahle J, Sikirica V, Setyawan J, Erder MH, Doshi JA. Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case. Eur Child Adolesc Psy. 2014;23(7):587–98.

Doshi JA, Hodgkins P, Kahle J, Sikirica V, Cangelosi MJ, Setyawan J, Erder MH, Neumann PJ. Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States. J Am Acad Child Adolesc Psychiatry. 2012;51(10):990–1002.e2.PubMed

Hakkaart-van Roijen L, Zwirs B, Bouwmans C, Tan SS, Schulpen T, Vlasveld L, Buitelaar J. Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD). Eur Child Adolesc Psy. 2007;16(5):316–26.

Pelham WE, Foster EM, Robb JA. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. Ambul Pediatr. 2007;7(1):121–31.PubMed

Van der Oord S, Prins PJ, Oosterlaan J, Emmelkamp PM. Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis. Clin Psychol Rev. 2008;28(5):783–800.PubMed

Swanson J. Compliance with stimulants for attention-deficit/hyperactivity disorder. CNS drugs. 2003;17(2):117–31.PubMed

International Narcotics Control Board. Annual Report 2014. New York: United Nations; 2015.

Swanson JM, Volkow ND. Psychopharmacology: concepts and opinions about the use of stimulant medications. J Child Psychol Psychiatry. 2009;50(1-2):180–93.PubMedPubMedCentral

10.

International Narcotics Control Board. Psychotropic Substances: Statistics for 2012 Assessments of Annual Medical and Scientific Requirements for Substances in Schedules II, III and IV of the Convention on Psychotropic Substances of 1971. New York: United Nations; 2014.

11.

Stichting Farmaceutische Kengetallen. Psychofarmaca bij jongeren vooral voor ADHD. 2013. http://www.sfk.nl/nieuws-publicaties/PW/2013/psychofarmaca_bij_jongeren_vooral_voor_ADHD. Accessed July 9 2015.

12.

Van Avendonk M, Stirbu-Wagner I, Korevaar J, Wiersma T. Meer kinderen met ADHD. Huisarts en wetenschap. 2014;57(11):595–5.

13.

Stichting Farmaceutische Kengetallen. Flinke stijging volwassen gebruikers methylfenidaat. 2014. http://www.sfk.nl/nieuws-publicaties/PW/2014/flinke-stijging-volwassen-gebruikers-methylfenidaat. Accessed July 9 2015.

14.

Schachter HM, Pham B, King J, Langford S, Moher D. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ. 2001;165(11):1475–88.PubMedPubMedCentral

15.

Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Jacobsen SJ. Modifiers of long-term school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a population-based study. J Dev Behav Pediatr. 2007;28(4):274–87.PubMed

16.

Gilmore A, Milne R. Methylphenidate in children with hyperactivity: review and cost–utility analysis. Pharmacoepidemiol Drug Saf. 2001;10(2):85–94.PubMed

17.

Buitelaar JK, Der Gaag V, Rutger J, Swaab-Barneveld H, Kuiper M. Prediction of Clinical Response to Methylphenidate in Children with Attention-Deficit Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 1995;34(8):1025–32.PubMed

18.

Spencer T, Biederman J, Wilens T, Harding M, O’Donnel D, Griffin S. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry. 1996;35(4):409–32.PubMed

19.

Carr A. The handbook of child and adolescent clinical psychology: A contextual approach. 2nd Revised edition ed. London: Routledge/Taylor & Francis Group; 2006.

20.

Taylor E, Döpfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E. European clinical guidelines for hyperkinetic disorder–first upgrade. Eur Child Adolesc Psy. 2004;13(1):i7–i30.

21.

National Collaborating Centre for Mental Health (UK). Attention Deficit Hyperactivity Disorder: The NICE Guideline on diagnosis and management of ADHD in children, young people and adults. Leicester: The British Psychological Society & The Royal College of Psychiatrists; 2009.

22.

Pliszka S, AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921.PubMed

23.

Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007–22.

24.

MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56(12):1073–86.

25.

Sonuga-Barke EJ, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M, Stevenson J, Danckaerts M, Van der Oord S, Döpfner M. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry. 2013;170(3):275–89.PubMed

26.

Fabiano GA, Pelham WE, Coles EK, Gnagy EM, Chronis-Tuscano A, O’Connor BC. A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder. Clin Psychol Rev. 2009;29(2):129–40.PubMed

27.

Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ. 1999;318(7183):593–6.PubMedPubMedCentral

28.

Storebo O, Ramstad E, Krogh H, Nilausen T, Skoog M, Holmskov M, Rosendal S, Groth C, Magnusson F, Moreira-Maia C. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD) (Review). Wiley Online Library. 2015.

29.

Walkup J. Practice parameter on the use of psychotropic medication in children and adolescents. J Am Acad Child Adolesc Psychiatry. 2009;48(9):961–73.

30.

Jensen PS, Garcia JA, Glied S, Crowe M, Foster M, Schlander M, Hinshaw S, Vitiello B, Arnold LE, Elliott G. Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. Am J Psychiatry. 2005;162(2):1628–36.PubMed

31.

Graham J, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Dittmann R, Döpfner M, Hamilton R, Hollis C, Holtmann M. European guidelines on managing adverse effects of medication for ADHD. Eur Child Adolesc Psy. 2011;20(1):17–37.

32.

Charach A, Ickowicz A, Schachar R. Stimulant treatment over five years: adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatry. 2004;43(5):559–67.PubMed

33.

Brown RT, Borden KA, Wynne ME, Schleser R, Clingerman SR. Methylphenidate and cognitive therapy with ADD children: a methodological reconsideration. J Abnorm Child Psychol. 1986;14(4):481–97.PubMed

34.

Abikoff H, Hechtman L, Klein RG, Weiss G, Fleiss K, Etcovitch J, Cousins L, Greenfield B, Martin D, Pollack S. Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry. 2004;43(7):802–11.PubMed

35.

Thiruchelvam D, Charach A, Schachar RJ. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2001;40(8):922–8.PubMed

36.

Elia J, Borcherding BG, Rapoport JL, Keysor CS. Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders? Psychiatry Res. 1991;36(2):141–55.PubMed

37.

Rapport MD, Denney C, DuPaul GJ, Gardner MJ. Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children. J Am Acad Child Adolesc Psychiatry. 1994;33(6):882–93.PubMed

38.

Adler LD, Nierenberg AA. Review of medication adherence in children and adults with ADHD. Postgrad Med J. 2010;122(1):184–91.

39.

Sleator EK, Ullmann RK, Von Neumann A. How do hyperactive children feel about taking stimulants and will they tell the doctor? Clin Pediatr (Phila). 1982;21(8):474–9.

40.

De Loo-Neus V, Gigi HH, Rommelse N, Buitelaar JK. To stop or not to stop? How long should medication treatment of attention-deficit hyperactivity disorder be extended? Eur Neuropsychopharmacol. 2011;21(8):584–99.PubMed

41.

Faraone SV, Biederman J, Morley CP, Spencer TJ. Effect of stimulants on height and weight: a review of the literature. J Am Acad Child Adolesc Psychiatry. 2008;47(9):994–1009.PubMed

42.

Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods AG, Arnold LE. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med. 2012;10:99–7015.PubMedPubMedCentral

43.

Molina BS, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, Epstein JN, Hoza B, Hechtman L, Abikoff HB. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry. 2009;48(5):484–500.PubMedPubMedCentral

44.

Kabat‐Zinn J. Mindfulness-based interventions in context: past, present, and future. Clin Psychol Sci Pract. 2003;10(2):144–56.

45.

Kabat-Zinn J. Wherever you go, there you are: Mindfulness meditation in everyday life. New York: Hyperion; 1994.

46.

Zoogman S, Goldberg SB, Hoyt WT, Miller L. Mindfulness interventions with youth: A meta-analysis. Mindfulness. 2014;6(2):290–302.

47.

Keng S, Smoski MJ, Robins CJ. Effects of mindfulness on psychological health: A review of empirical studies. Clin Psychol Rev. 2011;31(6):1041–56.PubMedPubMedCentral

48.

Shapiro SL, Carlson LE, Astin JA, Freedman B. Mechanisms of mindfulness. J Clin Psychol. 2006;62(3):373–86.PubMed

49.

Kabat-Zinn J. Full catastrophe living: The program of the stress reduction clinic at the University of Massachusetts Medical Center. New York: Delta; 1990.

50.

Segal ZV, Williams JMG, Teasdale JD. Mindfulness-based cognitive therapy for depression. New York: Guilford Press; 2012.

51.

Goyal M, Singh S, Sibinga EM, Gould NF, Rowland-Seymour A, Sharma R, Berger Z, Sleicher D, Maron DD, Shihab HM. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Internal Medicine. 2014;174(3):357–68.PubMedPubMedCentral

52.

Khoury B, Lecomte T, Fortin G, Masse M, Therien P, Bouchard V, Chapleau M, Paquin K, Hofmann SG. Mindfulness-based therapy: A comprehensive meta-analysis. Clin Psychol Rev. 2013;33(6):763–71.PubMed

53.

Hofmann SG, Sawyer AT, Witt AA, Oh D. The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review. J Consult Clin Psychol. 2010;78(2):169.PubMedPubMedCentral

54.

Lakhan SE, Schofield KL. Mindfulness-based therapies in the treatment of somatization disorders: a systematic review and meta-analysis. PLoS ONE. 2013;8(8), e71834.PubMedPubMedCentral

55.

Chiesa A, Serretti A. Mindfulness-based interventions for chronic pain: a systematic review of the evidence. J Altern Complement Med. 2011;17(1):83–93.PubMed

56.

Kabat-Zinn J, Lipworth L, Burney R. The clinical use of mindfulness meditation for the self-regulation of chronic pain. J Behav Med. 1985;8(2):163–90.PubMed

57.

Gu J, Strauss C, Bond R, Cavanagh K. How do mindfulness-based cognitive Therapy and mindfulness-based stress reduction improve mental health and wellbeing? A systematic review and meta-analysis of mediation studies. Clin Psychol Rev. 2015;37:1–12.PubMed

58.

Kuyken W, Watkins E, Holden E, White K, Taylor RS, Byford S, Evans A, Radford S, Teasdale JD, Dalgleish T. How does mindfulness-based cognitive therapy work? Behav Res Ther. 2010;48(11):1105–12.PubMed

59.

Bögels S, Hoogstad B, Van Dun L, De Schutter S, Restifo K. Mindfulness training for adolescents with externalizing disorders and their parents. Behav Cogn Psychother. 2008;36(02):193–209.

60.

Singh NN, Singh AN, Lancioni GE, Singh J, Winton AS, Adkins AD. Mindfulness training for parents and their children with ADHD increases the children’s compliance. J Child Fam Stud. 2010;19(2):157–66.

61.

Zylowska L, Ackerman DL, Yang MH, Futrell JL, Horton NL, Hale TS, Pataki C, Smalley SL. Mindfulness meditation training in adults and adolescents with ADHD: a feasibility study. J Atten Disord. 2008;11(6):737–46.PubMed

62.

Haydicky J, Wiener J, Badali P, Milligan K, Ducharme JM. Evaluation of a mindfulness-based intervention for adolescents with learning disabilities and co-occurring ADHD and anxiety. Mindfulness. 2012;3(2):151–64.

63.

Haydicky J, Shecter C, Wiener J, Ducharme JM. Evaluation of MBCT for adolescents with ADHD and their parents: Impact on individual and family functioning. J Child Fam Stud. 2015;24(1):76–94.

64.

C S. Mindfulness Training for Adolescents with ADHD and their Families: A Time-series Evaluation. Doctoral Dissertation. Toronto: University of Toronto; 2013.

65.

Van der Oord S, Bögels SM, Peijnenburg D. The effectiveness of mindfulness training for children with ADHD and mindful parenting for their parents. J Child Fam Stud. 2012;21(1):139–47.PubMed

66.

Van de Weijer-Bergsma E, Formsma AR, De Bruin EI, Bögels SM. The effectiveness of mindfulness training on behavioral problems and attentional functioning in adolescents with ADHD. J Child Fam Stud. 2012;21(5):775–87.PubMed

67.

Burke CA. Mindfulness-based approaches with children and adolescents: A preliminary review of current research in an emergent field. J Child Fam Stud. 2010;19(2):133–44.

68.

Braet C, Wante L, Bögels SM, Roelofs J. SCID-Junior. Unpublished manuscript. 2015.

69.

Wechsler D, Golombok S, Rust J. WISC-III Wechsler Intelligence Scale for Children. Sidcup: The Psychological Corporation. 1992.

70.

Kort DW, Compaan E, Bleichrodt N, Resing W, Schittekatte M, Bosmans M, Vermeir G, Verhaeghe P. WISC-III NL Dutch Manual. Amsterdam: NIP; 2002.

71.

Sattler J. Assessment of Children: Cognitive Applications. 4th ed. San Diego: Jerome M. Sattler Publisher; 2001.

72.

Bögels S, Restifo K. Mindful parenting: A guide for mental health practitioners. New York: Springer; 2014.

73.

Trimbos-instituut. Multidisciplinaire richtlijn voor diagnostiek en behandeling van ADHD bij kinderen en jeudigen. Utrecht: Trimbos-instituut; 2005.

74.

Oosterlaan J, Scheres A, Antrop I, Roeyers H, Sergeant J. Handleiding bij de vragenlijst voor gedragsproblemen bij kinderen [Manual of the Rating Scale for Disruptive Behavior Disorders in Children-DBDRS]. Lisse, The Netherlands: Swets Test. 2000.

75.

Achenbach TM. Integrative guide for the 1991 CBCL/4-18, YSR, and TRF profiles. University of Vermont: Department of Psychiatry. 1991.

76.

McConaughy SH, Achenbach TM. Manual for the test observation form for ages 2-18. ASEBA. 2004.

77.

Manly T, Robertson IH, Anderson V, Nimmo-Smith I. The Test of Everyday Attention (TEA-Ch). Bury St. Edmunds: Thames Valley Test Company; 1994.

78.

Schittekatte M, Groenvynck H, Fontaine J, Dekker P. Aanvullend psychometrisch onderzoek met de Test of Everyday Attention for Children (TEA-Ch): In Nederland en Vlaanderen aangepaste normen en validiteits-en betrouwbaarheidsgegevens. Additional psychometric evaluation of the Test of Everyday Attention for Children (TEA-Ch-NL): norms, validity and reliability measures for Dutch and Flemish children). Amsterdam: Harcourt Assessment; 2007.

79.

Brickenkamp R, Zillmer E. The D2 Test of Attention. Ashland: Hogrefe & Huber Pub; 1998.

80.

Hartong I, Krol M, Maaskant A, Te Plate A, Schuszler D, Meijer A. Stress Vragenlijst voor Kinderen (SVK). Amsterdam: Universiteit van Amsterdam, Afdeling Pedagogische en Onderwijskundige Wetenschappen; 2003.

81.

Topp CW, Østergaard SD, Søndergaard S, Bech P. The WHO-5 Well-Being Index: A Systematic Review of the Literature. Psychother Psychosom. 2015;84(3):167–76.PubMed

82.

Lyubomirsky S, Lepper HS. A measure of subjective happiness: Preliminary reliability and construct validation. Soc Indicators Res. 1999;46(2):137–55.

83.

Meijer A. Chronic sleep reduction, functioning at school and school achievement in preadolescents. J Sleep Res. 2008;17(4):395–405.PubMed

84.

Meijer AM, Den Wittenboer V, Godfried LH. The joint contribution of sleep, intelligence and motivation to school performance. Personal Individ Differ. 2004;37(1):95–106.

85.

Kerkhof GA, Geuke ME, Brouwer A, Rijsman RM, Schimsheimer RJ, Van Kasteel V. Holland Sleep Disorders Questionnaire: a new sleep disorders questionnaire based on the International Classification of Sleep Disorders-2. J Sleep Res. 2013;22(1):104–7.PubMed

86.

Kooij SJ, Buitelaar JK, Van den Oord E, Rijnders CA, Hodiamont PP. Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychol Med. 2005;35(6):817–27.PubMed

87.

Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;385–396.

88.

Roberti JW, Harrington LN, Storch EA. Further psychometric support for the 10‐Item Version of the Perceived Stress Scale. J Coll Couns. 2006;9(2):135–47.

89.

Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.PubMed

90.

Ohan JL, Leung DW, Johnston C. The Parenting Sense of Competence scale: Evidence of a stable factor structure and validity. Canadian Journal of Behavioural Science/Revue canadienne des sciences du comportement. 2000;32(4):251.

91.

Johnston C, Mash EJ. A measure of parenting satisfaction and efficacy. J Clin Child Psychol. 1989;18(2):167–75.

92.

Greco LA, Baer RA, Smith GT. Assessing mindfulness in children and adolescents: development and validation of the Child and Adolescent Mindfulness Measure (CAMM). Psychol Assess. 2011;23(3):606.PubMed

93.

De Bruin EI, Zijlstra BJ, Bögels SM. The meaning of mindfulness in children and adolescents: further validation of the Child and Adolescent Mindfulness Measure (CAMM) in two independent samples from the Netherlands. Mindfulness. 2014;5(4):422–30.

94.

Gill CM, Hodgkinson GP. Development and validation of the Five-Factor Model Questionnaire (FFMQ): An adjectival-based personality inventory for use in occupational settings. Pers Psychol. 2007;60(3):731–66.

95.

De Bruin EI, Topper M, Muskens JG, Bögels SM, Kamphuis JH. Psychometric properties of the Five Facets Mindfulness Questionnaire (FFMQ) in a meditating and a non-meditating sample. Assessment. 2012;19(2):187–97.PubMed

96.

Duncan LG. Assessment of mindful parenting among parents of early adolescents: Development and validation of the Interpersonal Mindfulness in Parenting scale. Doctoral dissertation. Pennsylvania: The Pennsylvania State University; 2007.

97.

De Bruin EI, Zijlstra BJ, Geurtzen N, Van Zundert RM, van de Weijer-Bergsma E, Hartman EE, Nieuwesteeg AM, Duncan LG, Bögels SM. Mindful parenting assessed further: Psychometric properties of the Dutch version of the Interpersonal Mindfulness in Parenting Scale (IM-P). Mindfulness. 2014;5(2):200–12.PubMed

98.

Neff KD. The development and validation of a scale to measure self-compassion. Self Identity. 2003;2(3):223–50.

99.

West AM. Mindfulness and well-being in adolescence: An exploration of four mindfulness measures with an adolescent sample. Doctoral Dissertation. Michigan: Central Michigan University; 2008.

100.

Braet C, Cracco E, Theuwis L. FEEL-KJ: vragenlijst voor emotieregulatie bij kinderen en jongeren. Amsterdam: Hogrefe; 2013.

101.

Suveg C, Sood E, Barmish A, Tiwari S, Hudson JL, Kendall PC. “ I’d rather not talk about it”: Emotion parenting in families of children with an anxiety disorder. J Fam Psychol. 2008;22(6):875.PubMedPubMedCentral

102.

Arnold DS, O’Leary SG, Wolff LS, Acker MM. The Parenting Scale: a measure of dysfunctional parenting in discipline situations. Psychol Assess. 1993;5(2):137.

103.

Harvey E, Danforth JS, Ulaszek WR, Eberhardt TL. Validity of the parenting scale for parents of children with attention-deficit/hyperactivity disorder. Behav Res Ther. 2001;39(6):731–43.PubMed

104.

Meins E. Sensitive attunement to infants’ internal states: Operationalizing the construct of mind-mindedness. Attach Hum Dev. 2013;15(5-6):524–44.PubMed

105.

Van Steensel FJ, Dirksen CD, Bögels SM. A cost of illness study of children with high-functioning autism spectrum disorders and comorbid anxiety disorders as compared to clinically anxious and typically developing children. J Autism Dev Disord. 2013;43(12):2878–90.PubMed

106.

Brooks R, EuroQol Group. EuroQol: the current state of play. Health Policy. 1996;37(1):53–72.PubMed

107.

Quené H, Van den Bergh H. On multi-level modeling of data from repeated measures designs: A tutorial. Speech Commun. 2004;43(1):103–21.

108.

Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods. 2008;40(3):879–91.PubMed

109.

Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: A non‐parametric approach to confidence interval estimation. Health Econ. 1997;6(4):327–40.PubMed

110.

Barkley RA. Global issues related to the impact of untreated attention-deficit/hyperactivity disorder from childhood to young adulthood. Postgrad Med J. 2008;120(3):48–59.

111.

Supino PG, Borer JS. Principles of research methodology: A guide for clinical investigators. New York: Springer; 2012.

112.

Murray D, Britton A, Bulstrode C. Loss to follow-up matters. J Bone Joint Surg (Br). 1997;79(2):254–7.

113.

Delgado-Rodriguez M, Llorca J. Bias. J Epidemiol Community Health. 2004;58(8):635–41.PubMedPubMedCentral

Title: Meditation or Medication? Mindfulness training versus medication in the treatment of childhood ADHD: a randomized controlled trial
Authors: Renée Meppelink
Esther I. de Bruin
Susan M. Bögels
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: BMC Psychiatry / Issue 1/2016
Electronic ISSN: 1471-244X
DOI: https://doi.org/10.1186/s12888-016-0978-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Meditation or Medication? Mindfulness training versus medication in the treatment of childhood ADHD: a randomized controlled trial

Abstract

Background

Methods/design

Discussion

Trial registration

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods/design

Discussion

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2016

Significant treatment effect of adjunct music therapy to standard treatment on the positive, negative, and mood symptoms of schizophrenic patients: a meta-analysis

Detection of unsafety in families with parental and/or child developmental problems at the start of family support

Online psycho-education to the treatment of bipolar disorder: protocol of a randomized controlled trial

Depression treatment decreases healthcare expenditures among working age patients with comorbid conditions and type 2 diabetes mellitus along with newly-diagnosed depression

Pathway to mental health recovery: a qualitative and quantitative study on the needs of Chinese psychiatric inpatients

Psychotic relapse and associated factors among patients attending health services in Southwest Ethiopia: a cross-sectional study